Once-daily pill for endometriosis approved for use on the NHS
A new at-home treatment option offers hope for women suffering from endometriosis.
The NHS has approved linzagolix, also known as Yselty, a once-daily pill designed to alleviate the debilitating symptoms of the condition.
Endometriosis affects an estimated 1.5 million women in the UK, causing tissue similar to the womb lining to grow elsewhere in the body. This can lead to a range of painful and disruptive symptoms, including severe pelvic pain, heavy periods, exhaustion, and fertility problems.
The current diagnostic process can be lengthy, with Nice reporting an average nine-year delay between the onset of symptoms and diagnosis.
Linzagolix offers a new approach to managing endometriosis by blocking specific hormones that contribute to the condition’s symptoms.
This new oral medication is expected to benefit up to 1,000 women annually, providing a more convenient and accessible treatment option.
